{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:09:42Z","timestamp":1770653382317,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.pharep.2016.03.011","type":"journal-article","created":{"date-parts":[[2016,3,27]],"date-time":"2016-03-27T02:12:02Z","timestamp":1459044722000},"page":"680-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Influence of caffeine on the protective activity of gabapentin and topiramate in a mouse model of generalized tonic-clonic seizures"],"prefix":"10.1007","volume":"68","author":[{"given":"Magdalena","family":"Chro\u015bci\u0144ska-Krawczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Jargie\u0142\u0142o-Baszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Andres-Mach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarogniew J.","family":"\u0141uszczki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanis\u0142aw J.","family":"Czuczwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2016.03.011_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(01)00181-8","article-title":"Caffeine dependence in teenagers","volume":"66","author":"Bernstein","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharep.2016.03.011_bib0255","first-page":"205","article-title":"Caffeine content of beverages as consumed","volume":"114","author":"Gilbert","year":"1976","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.pharep.2016.03.011_bib0260","first-page":"965","article-title":"Caffeine and antiepileptic drugs: experimental and clinical data","volume":"64","author":"Jankiewicz","year":"2007","journal-title":"Przeg Lek"},{"key":"10.1016\/j.pharep.2016.03.011_bib0265","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-0173(92)90012-B","article-title":"Caffeine and the central nervous system: mechanism of action, biochemical, metabolic and psychostimulant effects","volume":"17","author":"Nehlig","year":"1992","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharep.2016.03.011_bib0270","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/0009-9236(95)90025-X","article-title":"Symphatomimetic effects of paraxantine and caffeine in humans","volume":"58","author":"Benowitz","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharep.2016.03.011_bib0275","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hup.218","article-title":"Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups","volume":"15","author":"Hameleers","year":"2000","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharep.2016.03.011_bib0280","first-page":"36","article-title":"Drugs which induce anxiety: caffeine","volume":"25","author":"Hughes","year":"1996","journal-title":"N Z J Psychol"},{"key":"10.1016\/j.pharep.2016.03.011_bib0285","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/j.1552-4604.1997.tb04356.x","article-title":"Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans","volume":"37","author":"Kaplan","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2016.03.011_bib0290","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0091-3057(95)00029-V","article-title":"Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation","volume":"52","author":"Richardson","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2016.03.011_bib0295","series-title":"Koffee and Tee","author":"Burgin","year":"1970"},{"key":"10.1016\/j.pharep.2016.03.011_bib0300","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1528-1157.1981.tb04335.x","article-title":"Caffeine- and aminophylline-induced seizures","volume":"22","author":"Chu","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2016.03.011_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(92)90454-C","article-title":"Different effects of various xanthines on pentylenetetrazoleinduced seizures in rats: an EEG and behavioural study","volume":"222","author":"Cutrufo","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2016.03.011_bib0310","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/PL00005027","article-title":"Convulsant effects of some xanthine derivatives in genetically epilepsy-prone rats","volume":"356","author":"De Sarro","year":"1997","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharep.2016.03.011_bib0315","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1059-1311(03)00079-7","article-title":"Heavy coffee drinking and epilepsy","volume":"13","author":"Bonilha","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.pharep.2016.03.011_bib0320","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1059-1311(03)00048-7","article-title":"Caffeinated beverages and decreased seizure control","volume":"12","author":"Kaufman","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.pharep.2016.03.011_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568026053386962","article-title":"Mechanisms of action of antiepileptic drugs","volume":"5","author":"Czapi\u0144ski","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pharep.2016.03.011_bib0330","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1043-6618(05)80092-1","article-title":"Modulation of the protective efficacy of common antiepileptic drugs by xanthine derivatives: implications for the clinical use of xanthines in epileptic patients","volume":"22","author":"Czuczwar","year":"1990","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharep.2016.03.011_bib0335","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1528-1157.1990.tb05382.x","article-title":"Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice","volume":"31","author":"Czuczwar","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2016.03.011_bib0340","first-page":"751","article-title":"Adenosine on endogenous modulator of innate immune system with therapeutic potential","volume":"29","author":"Kumar","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2016.03.011_bib0345","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0361-9230(02)00759-1","article-title":"Changes of cortical epileptic afterdischarges under the influence of convulsant drugs","volume":"58","author":"Koryntov\u00e1","year":"2002","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharep.2016.03.011_bib0350","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1734-1140(09)70137-9","article-title":"Effect of caffeine on the anticonvulsant effects of oxcarbazepine, lamotrigine, and tiagabine in a mouse model of generalized tonic-clonic seizures","volume":"61","author":"Chro\u015bci\u0144ska-Krawczyk","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2016.03.011_bib0355","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1528-1157.1996.tb00023.x","article-title":"Anticonvulsant activity of phenobarbital and valproate against maximal electroshock in mice during chronic treatment with caffeine and caffeine discontinuation","volume":"37","author":"G\u0105sior","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2016.03.011_bib0360","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.0013-9580.2004.05104.x","article-title":"Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis","volume":"45","author":"\u0141uszczki","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2016.03.011_bib0365","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.npp.1300243","article-title":"Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice","volume":"28","author":"\u0141uszczki","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharep.2016.03.011_bib0370","first-page":"81","article-title":"Une nouvelle methode simple pour explorer l\u2019action \u201etranquillisante\u201d: le test de la cheminee","volume":"3","author":"Boissier","year":"1960","journal-title":"Med Exp"},{"key":"10.1016\/j.pharep.2016.03.011_bib0375","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.pharep.2016.03.011_bib0380","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0091-3057(95)02222-8","article-title":"Chronic caffeine and the anticonvulsant potency of antiepileptic drugs against maximal electroshock","volume":"54","author":"G\u0105sior","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2016.03.011_bib0385","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1046\/j.1528-1157.2002.34301.x","article-title":"Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis","volume":"43","author":"Borowicz","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2016.03.011_bib0390","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1528-1157.2003.45202.x","article-title":"Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy","volume":"44","author":"Borowicz","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2016.03.011_bib0395","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2016.03.011_bib0400","first-page":"782","article-title":"How significant is the difference between drug doses influencing the threshold for electroconvulsions?","volume":"57","author":"\u0141uszczki","year":"2005","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2016.03.011_bib0405","first-page":"116","article-title":"Caffeine and management of epilepsy \u2013 a clinical evidence","volume":"59","author":"B\u0142aszczyk","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2016.03.011_bib0410","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1528-1167.2005.463007.x","article-title":"An introduction to antiepileptic drugs","volume":"46","author":"Perucca","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2016.03.011_bib0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-1211(95)00028-9","article-title":"Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA","volume":"22","author":"Goldlust","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharep.2016.03.011_bib0420","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0304-3940(91)90249-S","article-title":"Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain","volume":"120","author":"L\u00f6scher","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2016.03.011_bib0425","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neuropharm.2004.06.014","article-title":"Caffeine-induced epileptiform field potentials in rat hippocampal slices: a pharmacological characterization","volume":"47","author":"Margineau","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2016.03.011_bib0430","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00023210-200115050-00001","article-title":"The new generation of GABA enhancers. Potential in the treatment of epilepsy","volume":"15","author":"Czuczwar","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharep.2016.03.011_bib0435","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","article-title":"The novel anticonvulsant drug, gabapentin (neurontin), binds to the \u03b12\u03b4 subunit of calcium channel","volume":"271","author":"Gee","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharep.2016.03.011_bib0440","first-page":"557","article-title":"Neuroprotective effects of antiepileptic drugs","volume":"54","author":"Trojnar","year":"2004","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharep.2016.03.011_bib0445","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0920-1211(97)00031-4","article-title":"Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin","volume":"28","author":"Dalby","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharep.2016.03.011_bib0450","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1528-1157.1993.tb02426.x","article-title":"Influence of chronic aminophylline on the anticonvulsant efficacy of phenobarbital and valproate in mice","volume":"34","author":"Czuczwar","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2016.03.011_bib0455","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1528-1157.1986.tb03529.x","article-title":"Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice","volume":"27","author":"Czuczwar","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2016.03.011_bib0460","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF01245350","article-title":"Anticonvulsant activity of carbamazepine and diphenylhydantoin against maximal electroshock in mice chronically treated with aminophylline","volume":"89","author":"Wlaz","year":"1992","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharep.2016.03.011_bib0465","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1528-1157.1993.tb02426.x","article-title":"Influence of chronic aminophylline on the anticonvulsant efficacy of phenobarbital and valproate in mice","volume":"34","author":"Wlaz","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2016.03.011_bib0470","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(87)90428-8","article-title":"Pro-convulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy","volume":"426","author":"Ault","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2016.03.011_bib0475","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-82-6-784","article-title":"Theophylline-induced seizures in adults. Correlation with serum concentrations","volume":"82","author":"Zwillich","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pharep.2016.03.011_bib0480","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1139\/Y07-046","article-title":"Anticonvulsant effect of A1 but not A2A adenosine receptors of piriform cortex in amygdala-kindled rats","volume":"85","author":"Rezvani","year":"2007","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pharep.2016.03.011_bib0485","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF01250573","article-title":"Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice","volume":"86","author":"Czuczwar","year":"1991","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharep.2016.03.011_bib0490","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1528-1157.1984.tb03449.x","article-title":"Interaction of anticonvulsant drugs with adenosine receptors in the central nervous system","volume":"25","author":"Weir","year":"1984","journal-title":"Epilepsia"}],"updated-by":[{"DOI":"10.1016\/j.pharep.2016.12.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000}}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016300044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016300044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:26Z","timestamp":1752611786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.03.011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1734114016300044"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.03.011","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.pharep.2016.12.008","asserted-by":"object"}]},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of caffeine on the protective activity of gabapentin and topiramate in a mouse model of generalized tonic-clonic seizures","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}